CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.
Clinical trial NCT03146533 · UNKNOWN
Trial details
- NCT number
- NCT03146533
- Sponsor
- Shenzhen Second People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2019-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.